🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →

IDXX NASDAQ 🇺🇸 US

IDEXX Laboratories, Inc.

Healthcare

Dip Signal

Price Zone: Strong Buy

🔒 Full AI Analysis — Pro

51Score

DipBuster Score™

$504.70 $1.83 (-0.36%) Live price · Source: Yahoo

52-Week Position

$500.61 2% of range $769.98

Beta

1.538

Moderate

Dividend

—

no income

Mkt Cap

N/A

total value

Mkt CapN/A

P/EN/A

DividendNone

Beta1.538

52W High$769.98

52W Low$500.61

DipBuster Brief Key signals at a glance

Zone: Strong Buy

Bullish

Near 52-Week Low — Wide Margin of Safety

At 2% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.

Neutral

Earnings Data Unavailable

P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.

Valuation

P/E Ratio—

Mkt CapN/A

52W Position2% of range

EV/EBITDA—

Cash Flow

FCF Yield—

FCF / Share

Op. Cash Flow—

Margins

Gross Margin—

Op. Margin—

Net Margin—

Balance Sheet

Cash—

Total Debt—

Net Cash—

Dividend

Yield—

Annual / shNone

Beta1.538

🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.

Charts

Create free account to see financial charts

🕵️ Insiders

📊 Valuation

💰 Dividends

📰 News

🤖 AI Analysis

Recent director dealings and insider transactions at IDEXX Laboratories, Inc. (IDXX), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date	Insider	Type	Shares
2026-08-20	Emerson Andrew	SELL	265
2026-08-20	Emerson Andrew	SELL	86
2026-08-20	Emerson Andrew	BUY	265
2026-07-30	Hooley Joseph L	BUY	49
2026-06-01	Fennell George	SELL	639
2026-06-01	Fennell George	SELL	284
2026-06-01	Fennell George	BUY	639
2026-05-12	Peacock Karen	BUY	234
2026-05-12	Peacock Karen	BUY	525
2026-05-12	Samad Sam	BUY	234

Valuation

P/E RatioN/A

Market CapN/A

Beta1.538

Dividend/yrNone

52W High$769.98

52W Low$500.61

52-Week Range

$500.61Now$769.98

2% through annual range

From 52W High−34.5%

From 52W Low+0.8%

📖 Plain English Summary

IDEXX Laboratories, Inc. is at 2% of its 52-week range. Beta 1.538 — significantly more volatile than the market.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…

Loading dividend data…

Latest news for IDXX 🟢 Bullish ⬜ Neutral 🔴 Bearish

🤖

DipBuster AI Analysis — IDXX

Heuristic · balance sheet, insider filings, price data, academic research

IDEXX Laboratories, Inc. — DipBuster Score 51/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒

Full AI Analysis — Pro

Price zones, Graham analysis, insider signals

Upgrade →

Track IDEXX Laboratories, Inc. free

Add IDXX to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Create free account → Log in

Sponsored · FCA Regulated Broker

Trading 212

Commission-free investing. ISA and GIA available. FCA regulated.

Free share worth up to £100 when you sign up

Open Free Account →

Capital at risk. Your investments can go down as well as up. Disclaimer

DipBuster Score™ Breakdown

Value & P/E 0/30

Dip Position 39/25

Momentum & Volume 7/25

Quality & Size 5/10

Insider Activity 0/10

🎯 Dip Buyer Signal

51 /100 · WATCH

dip depth 17/25

oversold rsi 18/25

mean reversion 15/15

insider zone 0/25

capitulation 0/10

Technical signal only. Not financial advice.

Quick Take

🟢

Dip Signal

DipBuster Score: 51/100

📊 Run a full check in the AI analysis tab for a deeper look.

Full AI analysis ↓ · How scores work

Company Profile

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestoc…

Sector Healthcare

Market 🇺🇸 US

CEO Michael Erickson

Staff 11,000 employees

Website idexx.com

Similar Stocks